Months after Abbott Nutrition—the largest infant formula manufacturer in the U.S.—initiated a voluntary recall of several lines of powdered formula, parents across the U.S. are still struggling to find formula in stores.
According to a May 12 news release from The White House, the voluntary recall came following concerns about bacterial contamination at Abbott Nutrition's facility in Sturgis, Michigan, after four infants fell ill and two died; the plant has since remained offline.
Following a slate of actions taken by the federal government to increase the supply and availability of infant formula, the U.S. Food and Drug Administration announced May 16 the filing of a proposed consent decree of permanent injunction between the FDA and Abbott Nutrition and that Abbott Nutrition agreed to take corrective actions following an FDA inspection of the Strugis facility.
"Today's action means that Abbott Nutrition has agreed to address certain issues that the agency identified in their infant formula production facility in Michigan. The public should rest assured that the agency will do everything possible to continue ensuring that infant and other specialty formulas produced by the company meet the FDA's safety and quality standards, which American consumers have come to expect and deserve," FDA Commissioner Dr. Robert M. Califf said in a statement. "We recognize the hardships that parents and caregivers have faces in obtaining infant formula and the FDA if focused on boosting the availability of the country's supply of these products, including new steps regarding importation. We are also taking a look at the supply of infant formulas development by manufacturers across the country and around the world to determine if a reallocation of their distribution can be made to help get the right product to the right place, at the right time."














